Concepedia

Madeline E. Kavanagh

ME

Statistics

Publications

16

Citations

791

H-Index

13

Active since

2013

Affiliations

University of Cambridge(Current)

University of Manchester

Scripps Research Institute

The University of Sydney

Neuroscience Research Australia

Madeline E. Kavanagh is an author at University of Cambridge specializing in pharmacology, drug discovery, and pharmacy.

ORCID

Publications per year

2013–2024

16

Publications

16

A proteome-wide atlas of lysine-reactive chemistry

Mikail E. Abbasov, Madeline E. Kavanagh, Taka-Aki Ichu et al. · Nature Chemistry · 2021 · 252 citations · Full text

, , +14

Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors

Jürgen Brem, Tharindi Panduwawala, Jon Hansen et al. · Nature Chemistry · 2021 · 83 citations · Full text

, , +13

Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine

Madeline E. Kavanagh, Benjamin D. Horning, Roli Khattri et al. · Nature Chemical Biology · 2022 · 78 citations · Full text

, , +14

Fragment-Based Approaches to the Development of<i>Mycobacterium tuberculosis</i>CYP121 Inhibitors

Madeline E. Kavanagh, Anthony G. Coyne, Kirsty J. McLean et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

, , +17

Effect of DMSO on Protein Structure and Interactions Assessed by Collision-Induced Dissociation and Unfolding

Daniel S-H. Chan, Madeline E. Kavanagh, Kirsty J. McLean et al. · Analytical Chemistry · 2017 · 58 citations · Full text

, , +17

1–5 of 16